The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zabolotskikh I.B.

FGBOU VO «Kuban State Medical University» Ministry of Health of Russia, Krasnodar, Russia

Trembach N.V.

FGBOU VO «Kuban State Medical University» Ministry of Health of Russia, Krasnodar, Russia

Butrov A.V.

RUDN University: PFUR, Moscow, Russia

Gorobets E.S.

FGBU «Russian Cancer Research Center named after N.N. Blokhin» Ministry of Health of Russia, Moscow, Russia

Grigor'ev E.V.

kafedra anesteziologii i reanimatologii Kemerovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Lebedinskii K.M.

FGBOU VO «North-West State Medical University named after I.I. Mechnikov» Ministry of Health of Russia, St. Petersburg, Russia

Lubnin A.Yu.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia, N.N. Burdenko Research Institute of Neurosurgery, Moscow, Russia, Department of Obstetrics and Gynecology, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia

Ovezov A.M.

MONIKI, Moscow, Russia

Ovechkin A.M.

FGAOU VO «The First Moscow State Medical University named after I.M. Sechenov» Ministry of Health of Russia, Moscow, Russia

Schegolev A.V.

N.N. Burdenko Main Military Clinical Hospital, Moscow, Russia ,SM Kirov Military Medical Academy, St. Petersburg, Russia

Perioperative management of patients with drug dependence

Authors:

Zabolotskikh I.B., Trembach N.V., Butrov A.V., Gorobets E.S., Grigor'ev E.V., Lebedinskii K.M., Lubnin A.Yu., Ovezov A.M., Ovechkin A.M., Schegolev A.V.

More about the authors

Read: 7613 times


To cite this article:

Zabolotskikh IB, Trembach NV, Butrov AV, et al. . Perioperative management of patients with drug dependence. Russian Journal of Anesthesiology and Reanimatology. 2018;(1):133‑145. (In Russ.)
https://doi.org/10.17116/anaesthesiology201801-021133

Recommended articles:

References:

  1. Manchikanti L, Singh A. Therapeutic opioids. A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(2 suppl):63-88.
  2. Gutstein HB, Akil H. Chapter 21. Opioid Analgesics. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, I: Accessed 30 Sep 2010. http://www.accessmedicine.com/content.aspx?aID=940653
  3. Wang Z, Fermini B, Nattel S. Mechanism of fl ecainide’s rate-dependent actions on action potential duration in canine atrial tissue. J Pharmacol Exp Ther. 1993;267:575-5781.
  4. Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol. 1994;34:902-911.
  5. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100(6):1040-1043.
  6. Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, et al. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J. 2010;31(3):318-329.
  7. Fukuda K. Intravenous opioid anesthetics. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia, PA: Elsevier; 2005.
  8. O’Brien C. Chapter 23. Drug addiction and drug abuse (Chapter). In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, lie: Accessed 30 Sep 2010. http://www.accessmedicine.com/content.aspx?aID=941547
  9. Solaini L, Gourgiotis S, Salemis NS, Koukis I. Bilateral pneumothorax, lung cavitations, and pleural empyema in a cocaine addict. Gen Thorac Cardiovasc Surg. 2008;56(12):610-612.
  10. Gotway MB, Marder SR, Hanks DK, Leung JW, Dawn SK, Gean AD, et al. Thoracic complications of illicit drug use: an organ system approach. Radiographics. 2002;22:119-135.
  11. Abramson DL, Gertler JP, Lewis T, Kral JG. Crack-related perforated gastropyloric ulcer. J Clin Gastroenterol. 1991;13(1):17-19.
  12. Heesch CM, Negus BH, Steiner M. Effects of in vivo cocaine administration on human platelet aggregation. Am J Cardiol. 1996;78:237-239.
  13. Stoelting RK. Opioids agonists and antagonists. In: Stoelting RK, Hillier S, editors. Pharmacology & physiology in anesthetic practice. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2006.
  14. Johnston LD, O’Malley PM, Bachman JG. Monitoring the future national results on adolescent drug use: overview of key findings (NIH Publication No. 10-7583). Bethesda, MD: National Institute on Drug Abuse; 2009.
  15. May JA, White HC, Leonard-White A. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg. 2001;92:160-161.
  16. Jage J, Bey T. Postoperative analgesia in patients with substance use disorders. Acute Pain. 2000;3:140-155.
  17. Sporer K, Dorn EA. Case series. Heroin-related noncardiogenic pulmonary. Chest. 2001;120:1628-1632.
  18. Doyon S. Chapter 167. Opioids. In: Tintinalli JE, Kelen GD, Stapczynski JS, Ma OJ, Cline DM, editors. Tintinalli’s emergency medicine: a comprehensive study guide, 6e: Accessed 30 Sep 2010. http://www.acce.ss-medicine.com.medlib.med.miami.edu:2048/content.aspx?aID=602227
  19. Nakao S. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients. Anesth Analg. 2010;110(3):775-779.
  20. Graeme KA. New drugs of abuse. Emerg Med Clin North Am. 2000;18:625-636.
  21. Nafziger AN, Bertino Jr JS. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009;25(1):73-79.
  22. Mahajan G. Role of Urine Drug Testing in the Current Opioid Epidemic. Anesth Analg. 2017;125(6):2094-2104.
  23. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003;23:802.
  24. Altmann D, Eggmann U, Ammann PW. Drug induced QT prolongation. Klin Wochenschr. 2008;120(5-6):128-135.
  25. Gupta A, Lawrence AT, Krishnan K. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J. 2007;153(6):891-899.
  26. Letsas KP, Efremidis M, Kounas SP. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol. 2009;98(4):208-212.
  27. Saybolta M, Altera S, Santosb F. Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation. 2010;81:42-46.
  28. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226-238.
  29. Nestler EJ. Molecular neurobiology of addiction. Am J Addict. 2001;10:201-217.
  30. Grigorakos L, Sakagianni K, Tsigou E. Outcome of acute heroin overdose requiring intensive care unit admission. J Opioid Manag. 2010;6(3):227-231.
  31. Mokhlesi B, Leiken J, Murray P. Adult toxicology in critical care: part II: specific poisonings. Chest. 2003;123:897-922.
  32. Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness: controversies in the use of a ‘coma cocktail’. JAMA. 1995;274:562.
  33. Schneir AB, Vadeboncoeur TF, Offerman SR. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med. 2002;40(4):425-428.
  34. Larpin R, Vincent A, Perret C. Hospital morbidity and mortality of acute opiate intoxication. Presse Med. 1990;19(30):1403-1406.
  35. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case controlled retrospective review. Pain. 1995;61:195-201.
  36. Tctrault JM, O’Connor PJ. Substance abuse and withdrawal in the critical care setting. Crit Care Clin. 2008;24:767-788.
  37. Mahathanaruk M, Hitt J, de LeonCasasola OA. Perioperative management of the opioid tolerant patient for orthopedic surgery. Anesthesiol Clin. 2014;32(4):923-932.
  38. Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009;22(5):588-593.
  39. Katz WA. Cyclooxygenase-2-selective inhibitors in the management of acute and perioperative pain. Cleve Clin J Med. 2002;69(suppl I):65-75.
  40. Bell RF, Dahl JB, Moore RA, Kalso E. Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand. 2005;49(10):1405-1428.
  41. Haller G, Waeber JL, Infante NK, Clergue F. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology. 2002;96:1265-1266.
  42. Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal [see comment]. N Engl J Med. 2003;348(18):1786-1795.
  43. Nicholls L, Bragaw L, Ruetsch C. Opioid dependence treatment and guidelines. J Manag Care Pharm. 2010;16(l suppl B):14-21.
  44. O’Connor PG, Samet JH, Stein MD. Management of hospitalized intravenous drug users: role of the internist. Am J Med. 1994;96:551-558.
  45. Mackenzie JW. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61:907-908.
  46. Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009;43(9):1506-1511.
  47. Tobias JD. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag. 2006;2:201-205.
  48. Patch RK, Eldrige JS, Moeschler SM, Pingree MJ. Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance. Case Rep Anesthesiol. 2017;9876306.
  49. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage. 2000;20:237-245.
  50. Laulin JP, Celerier E, Larcher A. Opiate tolerance to daily heroin administration. An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience. 1999;89:631-636.
  51. Camf J, Farre M. Drug addiction. N Engl J Med. 2003;349:975-986.
  52. Ovechkin AM, Politov ME. Postoperative analgesia in terms of evidence-based medicine. Vestnik intensivnoy terapii. 2016;2:51-60. (In Russ.)
  53. Mehta V, Langford RM. Pain management for opioid dependent patients. Anaesthesia. 2006;61:269-276.
  54. Weinbroum AA, Gorodetzky A, Nirkin A. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Cancer. 2002;95:1164-1170.
  55. Helmy SA, Bali A. The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesth Analg. 2001;92:739-744.
  56. Barton SF, Langeland FF, Snabes MC. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology. 2002;97:306-314.
  57. Angst MS, Clark JD. Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain: a unique indication? Anesthesiology. 2010;113(3):514-515.
  58. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;3:2-25.
  59. Barr J, Pandharipande PP. The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion. Crit Care Med. 2013;41(9 suppl 1):99-115.
  60. Hill GE, Ogunnaike BO, Johnson ER. General anaesthesia for the cocaine abusing patient: is it safe? Br J Anaesth. 2006;97:654-657.
  61. Chestnut DH. Substance abuse. In: Obstetric anesthesia: principle and practice, 3rd ed. New York, NY: Elsevier Mosby; 2004.
  62. Birnbach DJ, Stein DJ. The substance-abusing parturient: implications for analgesia and anesthesia management. Baillieres Clin Obstet Gynaecol. 1998;12:443-460.
  63. Susskind H, Weber DA, Volkow ND, Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest. 1991;100:903-909.
  64. Baldwin GC, Choi R, Roth MD. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal («crack») cocaine. Chest. 2002;121:1231-1238.
  65. Norris KC, Thornhill-Joynes M, Robinson C. Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis. 2001;38:523-528.
  66. Kuckowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382-394.
  67. McCord J, Jneid H, Hollander JE. Management of cocaine-associated chest pain and myocardial infarction: a scientifi c statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897-1907.
  68. Battaglia G, Napier TC. The effects of cocaine and the amphetamines on brain and behavior: a conference report. Drug Alcohol Depend. 1998;52:41-48.
  69. Myasnikova VV, Karahalis NB, Musaeva TS. Management of patients with bradyarrhythmias in the perioperative period in noncardiac surgery. Vestnik intensivnoy terapii. 2017;3:5-18. (In Russ.)
  70. Myasnikova VV, Karahalis NB, Musaeva TS, Zabolotskikh IB. Management of patients with tachyarrhythmias in the perioperative period in noncardiac surgical procedures. Vestnik intensivnoy terapii. 2017;2:37-55. (In Russ.)
  71. O’Cain PA, Hletko SB, Ogden BA. Cardiovascular and sympathetic responses and refl ex changes elicited by MDMA. Physiol Behav. 2000;70:141-148.
  72. Walsh T, Carmichale R, Chestnut J. A hyperthermic reaction to ecstasy. Br J Hosp Med. 1994;51:476.
  73. Gill JR, Hayes JA, de Souza IS. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forensic Sci. 2002;47:121-126.
  74. Hall AP. «Ecstasy» and the anaesthetist. Br J Anaesth. 1997;79:697-698.
  75. Rusyniak DE, Sprague JE. Toxin-induced hyperthermic syndromes. Med Clin North Am. 2005;89(6):1277-1296.
  76. Ghuran A, Nolan J. Recreational drug misuse: issues for the cardiologist. Heart. 2000;83:627-633.
  77. Qasim A, Townend J, Davies MK. Ecstasy induced acute myocardial infarction. Heart. 2001;85:E10.
  78. Ghuran A, van Der Wieken LR, Nolan J. Cardiovascular complications of recreational drugs. BMJ. 2001;323:464-466.
  79. Brody S, Krause C, Veit R, Rau H. Cardiovascular autonomic dysregulation in users of MDMA («Ecstasy»). Psychopharmacology. 1998;136:390-393.
  80. Kessel B. Hyponatraemia after ingestion of «Ecstasy». BMJ. 1994;308:414.
  81. Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after «Ecstasy» (3,4-MDMA) [letter]. Lancet. 1996;347:1052.
  82. Klein M, Kramer F. Rave drugs: pharmacological considerations. AANA J. 2004;72:61-67.
  83. Reneman L, Habraken JB, Majoie CB. MDMA («Ecstasy») and its association with cerebrovascular accidents: preliminary findings. Am J Neuroradiol. 2000;21:1001-1007.
  84. Singarajah C, Lavies NG. An overdose of ecstasy: a role for dantrolene. Anaesthesia. 1992;47:686-687.
  85. Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. J Subst Abuse Treat. 2002;23:151-156.
  86. McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J Psychoactive Drugs. 2001;33(2):143-149.
  87. Muronov AE. Perioperative management of patients with alcohol dependence. Vestnik intensivnoy terapii. 2017;2:61-68. (In Russ.)
  88. Weiner AL, Viera L, McKay CA, Bayer MJ. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med. 2000;18:447-451.
  89. Pal HR, Berry N, Kumar R. Ketamine dependence. Anaesth Intensive Care. 2002;30:382-384.
  90. Hassan SF, Wearne TA, Cornish JL, Goodchild AK. Effects of acute and chronic systemic methamphetamine on respiratory, cardiovascular and metabolic function, and cardiorespiratory reflexes. J Physiol. 2016;594(3):763-780.
  91. Yoshida S, Kinoshita H, Tatara T, Tashiro C, Nishiguchi M, Ouchi H, Minami T, Hishida S. Involvement of glucocorticoid receptor on hyperpyrexia induced by methamphetamine administration. Soud Lek. 2012;57(4):66-68.
  92. Beaulieu P. Anesthetic implications of recreational drug use. Can J Anaesth. 2017;64(12):1236-1264.
  93. Flisberg P, Paech MJ, Shah T, Ledowski T, Kurowski I, Parsons R. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol. 2009;26:192-195.
  94. Pertwee RG. Neuropharmacology and therapeutic potential of cannabinoids. Addict Biol. 2000;5:37-46.
  95. Clifford T. Marijuana. J Perianesth Nurs. 2016;31(6):547-549.
  96. Perron BE, Howard MO. Adolescent inhalant use, abuse and dependence. Addiction. 2009;104:1185-1192.
  97. Turowski SG, Jank KE, Fung HL. Inactivation of hepatic enzymes by inhalant nitrite--in vivo and in vitro studies. AAPS J. 2007;9(3):298-305.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.